Published in J Neurosci on October 29, 2008
Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood (2010) 2.45
Chemical probes of endocannabinoid metabolism. Pharmacol Rev (2013) 1.68
The endocannabinoid system and pain. CNS Neurol Disord Drug Targets (2009) 1.59
The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol (2011) 1.46
Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci (2014) 1.25
The analgesic potential of cannabinoids. J Opioid Manag (2010) 1.16
Cancer Pain: A Critical Review of Mechanism-based Classification and Physical Therapy Management in Palliative Care. Indian J Palliat Care (2011) 1.14
Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons. J Neurosci (2012) 1.10
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Br J Haematol (2011) 1.09
R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One (2010) 1.08
Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget (2014) 1.05
Mechanism of cancer pain. Mol Interv (2010) 1.00
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat Rev Drug Discov (2012) 0.99
Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain. Br J Pharmacol (2010) 0.98
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. Pharmacol Res (2011) 0.97
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. J Neurosci (2012) 0.96
Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain. PLoS One (2010) 0.91
Mode of action of cannabinoids on nociceptive nerve endings. Exp Brain Res (2009) 0.90
A lipid gate for the peripheral control of pain. J Neurosci (2014) 0.88
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats. Pain (2012) 0.87
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. J Biol Chem (2012) 0.85
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. Br J Pharmacol (2010) 0.83
Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons. Neuropharmacology (2011) 0.82
CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain. Behav Pharmacol (2011) 0.82
The neurobiology of cancer pain. Neuroscientist (2014) 0.81
Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiol Dis (2013) 0.81
Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons. Brain Struct Funct (2012) 0.80
Increased expression of cannabinoid CB₁ receptors in Achilles tendinosis. PLoS One (2011) 0.77
Alterations in the anandamide metabolism in the development of neuropathic pain. Biomed Res Int (2014) 0.76
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy. J Neurophysiol (2014) 0.76
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. Pharmacol Res (2014) 0.75
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain. Neuroscience (2013) 0.75
Endocannabinoids as Guardians of Metastasis. Int J Mol Sci (2016) 0.75
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. Pain (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 13.45
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A (2001) 7.15
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (1994) 5.70
Control of pain initiation by endogenous cannabinoids. Nature (1998) 4.73
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39
An endocannabinoid mechanism for stress-induced analgesia. Nature (2005) 4.03
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A (2002) 3.16
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther (2004) 3.14
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain (2004) 2.94
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci (2007) 2.78
Cannabinoid receptors and pain. Prog Neurobiol (2001) 2.48
Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience (2000) 2.28
Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids (2002) 2.15
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J Neurosci (2006) 2.02
Therapy of metastatic bone pain. J Nucl Med (2001) 1.94
Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. Br J Pharmacol (2005) 1.84
Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem (1999) 1.82
Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience (1999) 1.73
Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci (2001) 1.58
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta (1995) 1.57
Differential response properties of IB(4)-positive and -negative unmyelinated sensory neurons to protons and capsaicin. J Neurophysiol (2003) 1.56
Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience (2000) 1.56
Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience (2003) 1.54
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett (1996) 1.52
A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry (2006) 1.51
Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci (2001) 1.50
Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol (2007) 1.49
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. EMBO J (2005) 1.48
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat (2000) 1.48
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br J Pharmacol (2008) 1.43
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci (2005) 1.41
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology (2001) 1.35
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol (1998) 1.34
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Br J Pharmacol (2006) 1.32
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J Neurosci (2006) 1.28
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br J Pharmacol (2007) 1.28
Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience (2003) 1.27
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain (2003) 1.25
Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci (2001) 1.24
The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor. J Pharmacol Exp Ther (1999) 1.23
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience (2003) 1.20
Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev (1998) 1.16
Differential expression of membrane currents in dissociated mouse primary sensory neurons. Neuroscience (1994) 1.16
The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J Neurosci (1999) 1.12
Evaluation of fatty acid amides in the carrageenan-induced paw edema model. Neuropharmacology (2007) 1.11
Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain (2002) 1.09
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. Pain (2006) 1.09
Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience (2007) 1.08
Bone cancer pain: from model to mechanism to therapy. J Pain Symptom Manage (2005) 1.07
Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci (2007) 1.07
Retracted Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J Neurochem (2003) 1.07
Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. J Neurosci (2007) 1.06
Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J Neurosci (2004) 1.06
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia. Eur J Pharmacol (2006) 1.06
Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience (2007) 1.05
Adult mouse dorsal root ganglia neurons in cell culture. J Neurobiol (1977) 1.05
Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology (2003) 1.04
Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience (2002) 1.03
Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res (1998) 1.01
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. Neuropharmacology (2006) 0.99
Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study. J Clin Oncol (2004) 0.99
Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience (2002) 0.98
Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs (2007) 0.98
Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain (2003) 0.97
Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience (2005) 0.96
Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Pharmacol Res (2007) 0.96
Peripheral cannabinoids attenuate carcinoma-induced nociception in mice. Neurosci Lett (2008) 0.96
Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience (2002) 0.95
Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol (2004) 0.94
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms. Brain Res (2008) 0.92
The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. Br J Pharmacol (1999) 0.92
Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res (2005) 0.92
Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol (2008) 0.88
Tumor osteolysis in osteopetrotic mice. J Orthop Res (1995) 0.86
Quantitative estimation of the effects of capsaicin on the mouse primary sensory neurons. Neurosci Lett (1987) 0.85
The multiple pathways of endocannabinoid metabolism: a zoom out. Chem Biodivers (2007) 0.84
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem (2004) 0.84
Actions of capsaicin on mouse dorsal root ganglion cells in vitro. Neurosci Lett (1993) 0.84
Managing cancer pain poorly responsive to systemic opioid therapy. Oncology (Williston Park) (1999) 0.83
Metastatic bone pain. Meanings associated with self-report and self-management decision making. Cancer Nurs (2000) 0.82
Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor. J Mol Signal (2008) 0.79
Treating bone metastases: sparing the patient needless pain. J Natl Cancer Inst (1997) 0.76
Diazepam as an adjuvant analgesic to morphine for pain due to skeletal muscle spasm. Support Care Cancer (2002) 0.76
The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci (2007) 2.63
Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood (2010) 2.45
Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood (2013) 1.94
Variation in quantitative sensory testing and epidermal nerve fiber density in repeated measurements. Pain (2010) 1.58
Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat Neurosci (2009) 1.51
Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med (2009) 1.45
Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci (2002) 1.42
Long-term modification of cortical synapses improves sensory perception. Nat Neurosci (2012) 1.31
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain (2003) 1.25
Pruriceptive spinothalamic tract neurons: physiological properties and projection targets in the primate. J Neurophysiol (2012) 1.18
Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons. J Neurosci (2012) 1.10
Neurotrophin activation of NFAT-dependent transcription contributes to the regulation of pro-nociceptive genes. J Neurochem (2007) 1.10
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Br J Haematol (2011) 1.09
Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. J Neurosci (2007) 1.06
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia. Eur J Pharmacol (2006) 1.06
Mechanism of cancer pain. Mol Interv (2010) 1.00
Re-organization of P2X3 receptor localization on epidermal nerve fibers in a murine model of cancer pain. Brain Res (2005) 1.00
Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease. Pain (2015) 0.98
Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation. J Neurophysiol (2008) 0.98
NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla. J Neurophysiol (2006) 0.98
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. Pharmacol Res (2011) 0.97
Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury. Pain (2004) 0.96
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. J Neurosci (2012) 0.96
Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain. Brain Res (2007) 0.93
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms. Brain Res (2008) 0.92
Tumor-evoked sensitization of C nociceptors: a role for endothelin. J Neurophysiol (2008) 0.90
NK-1 receptors in the rostral ventromedial medulla contribute to hyperalgesia produced by intraplantar injection of capsaicin. Pain (2008) 0.88
Excitation of cutaneous C nociceptors by intraplantar administration of anandamide. Brain Res (2009) 0.87
Characterization of cutaneous primary afferent fibers excited by acetic acid in a model of nociception in frogs. J Neurophysiol (2003) 0.86
Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res (2012) 0.85
Spinal neurons that express NK-1 receptors modulate descending controls that project through the dorsolateral funiculus. J Neurophysiol (2004) 0.85
Changes in response properties of nociceptive dorsal horn neurons in a murine model of cancer pain. Sheng Li Xue Bao (2008) 0.85
Termination zones of functionally characterized spinothalamic tract neurons within the primate posterior thalamus. J Neurophysiol (2008) 0.83
Differential modulation of neurons in the rostral ventromedial medulla by neurokinin-1 receptors. J Neurophysiol (2011) 0.82
CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain. Behav Pharmacol (2011) 0.82
Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiol Dis (2013) 0.81
Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons. Neurosci Lett (2006) 0.81
Cannabinoid agonist, CP 55,940, prevents capsaicin-induced sensitization of spinal cord dorsal horn neurons. J Neurophysiol (2004) 0.80
Nerve growth factor treatment enhances release of immunoreactive calcitonin gene-related peptide but not substance P from spinal dorsal horn slices in rats. Neurosci Lett (2004) 0.78
SYM 2081, an agonist that desensitizes kainate receptors, attenuates capsaicin and inflammatory hyperalgesia. Brain Res (2003) 0.77
Sex differences in neuropeptide content and release from rat dental pulp. J Endod (2011) 0.76
Changes in response properties of nociceptors and dorsal horn neurons in a murine model of cancer pain. Fiziol Zh (2011) 0.75
A role for nk-1 neurons in the rostral ventromedial medulla in the development of chronic post-thoracotomy pain. Pain (2017) 0.75
A role for neurokinin-1 receptor neurons in the rostral ventromedial medulla in the development of chronic postthoracotomy pain. Pain (2017) 0.75
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. Pain (2017) 0.75